Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Cash on Hand

Cash on Hand as of June 2024 : NZ$1.43 B

According to Lundbeck 's latest financial reports the company has NZ$1.43 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lundbeck - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.17 B51.21%
2022-12-31NZ$0.77 B53.15%
2021-12-31NZ$0.50 B-43.82%
2020-12-31NZ$0.90 B34.72%
2019-12-31NZ$0.66 B-55.81%
2018-12-31NZ$1.51 B81.49%
2017-12-31NZ$0.83 B84.18%
2016-12-31NZ$0.45 B38.99%
2015-12-31NZ$0.32 B-57.32%
2014-12-31NZ$0.76 B-42.16%
2013-12-31NZ$1.32 B60.62%
2012-12-31NZ$0.82 B-6.57%
2011-12-31NZ$0.88 B61.39%
2010-12-31NZ$0.54 B1.09%
2009-12-31NZ$0.53 B-57.24%
2008-12-31NZ$1.26 B181.12%
2007-12-31NZ$0.44 B51.55%
2006-12-31NZ$0.29 B179.06%
2005-12-31NZ$0.10 B-23.23%
2004-12-31NZ$0.13 B